共 288 条
[1]
Alatrash G(2016)Targeting immune checkpoints in hematologic malignancies Pharmacol Rev 68 1014-1025
[2]
Daver N(2012)Donor CTLA-4 genotype influences clinical outcome after T cell-depleted allogeneic hematopoietic stem cell transplantation from HLA-identical sibling donors Biol Blood Marrow Transpl 18 100-105
[3]
Mittendorf EA(2002)Cytotoxic T Lymphocyte Antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength Immunity 16 23-35
[4]
Bosch-Vizcaya A(2006)Inhibition of T cell activation and autoimmune diabetes using a B cell surface–linked CTLA-4 agonist J Clin Investig 116 2252-2261
[5]
Pérez-García A(1988)A class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Statist 16 1141-1154
[6]
Brunet S(2012)Genetic variation in donor CTLA-4 regulatory region is a strong predictor of outcome after allogeneic hematopoietic cell transplantation for hematologic malignancies Biol Blood Marrow Transpl 18 1069-1075
[7]
Solano C(2015)A CT60G>A polymorphism in the CTLA-4 gene of the recipient may confer susceptibility to acute graft versus host disease after allogeneic hematopoietic stem cell transplantation Immunogenetics 67 295-304
[8]
Buño I(1995)CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation J Exp Med 182 459-465
[9]
Guillem V(2010)CTLA-4 is expressed by human monocyte—derived dendritic cells and regulates their functions Hum Immunol 71 934-941
[10]
Martínez-Laperche C(1992)Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule Science 257 792-795